←Back to Expert Scholars
Translational Medicine / 转化医学FGFR Inhibitor Therapy
Lipika Goyal
MD
🏢Stanford University🌐USA
Associate Professor of Medicine
50
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Lipika Goyal is a leader in cholangiocarcinoma research and FGFR targeted therapy. She led FOENIX CCA2 evaluating futibatinib in FGFR2 fusion positive intrahepatic cholangiocarcinoma. Her work defines resistance mechanisms and next generation FGFR inhibitor strategies. She is among the leading experts in hepatobiliary precision oncology.
Share:
🧪Research Fields 研究领域
cholangiocarcinoma
FGFR inhibitors
hepatobiliary cancer
targeted therapy
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Lipika Goyal 的研究动态
Follow Lipika Goyal's research updates
留下邮箱，当我们发布与 Lipika Goyal（Stanford University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment